LIfT BioSciences is a series b startup based in United Kingdom. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
LIfT BioSciences is an immuno-oncology company developing a cell therapy called Neutrophil Only Lymphocyte Induced Targeting (N-LIfT).
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky